Implant chemotherapy port - Sisterangela

Procedure or Surgery Associated with Neuroendocrine Carcinoma, Unknown Primary. Posted on January 10, 2012 View this journey (15 Experiences)

Went as Expected: Strongly Agree
Minimal Recovery: Strongly Agree
Minimal Side Effects: Strongly Agree
Minimal Impact to Daily Life: Strongly Agree

Read more Neuroendocrine Carcinoma, Unknown Primary experiences about Implant chemotherapy port.

Read and answer Neuroendocrine Carcinoma, Unknown Primary questions.